Danone Expands Infant Milk Recall to Six European Countries Following Detection of Cereulide
On February 5, 2026, Danone announced the expansion of its infant milk recalls in France, Poland, Austria, Germany, Hungary, Romania, and Switzerland. This decision affects several hundred batches of products in response to new recommendations from the European Food Safety Authority (EFSA) concerning cereulide toxin.
The recall covers several hundred batches, including more than 120 in Austria and Germany, and 119 in France. The affected brands include Gallia and Blédilait. The list can be viewed here on the Signal Conso website.
Reason for the Recall
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
This recall follows the EFSA's update of its recommendations on the tolerated threshold of cereulide toxin in infant formulas. Cereulide is a toxin produced by certain bacteria, which can cause diarrhea and vomiting in infants.
Health Authorities' Recommendations
Health authorities advise parents not to use the affected products and to return them to the point of sale. They have also ruled out the risk of an infant milk shortage following these recalls.
SectorAgroalimentaire · Grande consommation›Produits alimentaires
Context
Period
Period: 1T2026
Key reported figures
Revenue: 6708M€
Guidance from the release
La performance du premier trimestre confirme, une nouvelle fois, la résilience, la solidité et la pertinence de notre portefeuille axé sur la santé.
Chiffre d'affaires en baisse de -2,0% en données publiées, mais croissance solide de +2,7% en données comparables.
Risks mentioned
Impact des rappels de laits infantiles en Europe sur la Nutrition Spécialisée.
Conflit au Moyen-Orient influençant la performance en EMEA.
Dépréciation de plusieurs devises par rapport à l'euro.
Opportunities identified
Acquisition de Huel renforçant notre présence dans la nutrition fonctionnelle.
Création d'une joint-venture avec Arcor ouvrant des opportunités dans les produits laitiers.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
